Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
COSCIENS Biopharma ( (TSE:CSCI) ) has shared an announcement.
On May 30, 2025, COSCIENS Biopharma Inc. announced an amendment to the date of its Annual General and Special Meeting of Security Holders, now scheduled for June 30, 2025, to be held virtually. The company is strategically sunsetting certain programs and focusing on the commercialization of its key products, which may impact its market positioning and stakeholder interests.
More about COSCIENS Biopharma
COSCIENS Biopharma Inc. operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical and nutraceutical products. The company is known for its patented technologies and value-driving products, including oat-based pipeline products and Macrilen® (macimorelin).
Average Trading Volume: 2,248
Technical Sentiment Signal: Sell
Current Market Cap: C$15.61M
For an in-depth examination of CSCI stock, go to TipRanks’ Stock Analysis page.